Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2

NCT03908749 is registered in ClinicalTrials.gov with Anhui Provincial Hospital as lead sponsor.

NCT NCT03908749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03908749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2
Lead sponsor
Anhui Provincial Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 10, 2019
Completion date
October 10, 2020
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

her2 positive breast carcinoma